Forbes Medi-Tech Inc. - Legal Notices

		TERMS OF USE AND DISCLAIMERS Forbes Medi-Tech Inc. maintains this website for personal informational purposes only. By accessing and browsing the Site, you accept, without limitation or qualification, these Terms of Use and disclaimers. Product Information - No Medical Advice Forbes distributes dietary supplements and nutraceutical products through its licensees in the U.S., New Zealand, Australia, Thailand, the UK and Finland in order to assist with the treatment and/or prevention of disease. The Corporation's products are intended only for use in countries in which they have received regulatory approval, under the direction of qualified health care professionals approved by government agencies in such countries. Material on this website regarding the Corporation's products is provided for information purposes only. Inclusion of products and information on this site does not imply any official medical advice, recommendation or warranty. Information provided is not a substitute for the advice of an appropriate health professional. This website can be accessed from countries around the world and may contain references to the Corporation's products and programs that have not been granted regulatory approval in your country. Please consult your physician for detailed information regarding the Corporation's products and their suitability for you, as well as for regulatory approval status of such products in your country. No Solicitation or Investment Advice The Forbes web site is provided as a service only and does not contain the official versions of Forbes' securities law disclosure documents. The site is not intended to provide specific investment advice and investors and potential investors are advised to seek professional advice and/or refer to Forbes' official documents filed with the Canadian securities regulatory authorities at www.sedar.com. Trademarks and Tradenames The Company owns and licenses a number of trademarks, tradenames, logos, products, processes, technologies and other intellectual property described in this website. Certain intellectual property of companies other than Forbes is used with permission of its owners by the Company. Reducol(tm) refers to Reducol(tm) blend phytosterol composition; Patents owned by Forbes Medi-Tech Inc. Copyright Images of people, places or things shown on this website are either the property of, or used with permission of their owners by the Company. Any unauthorized use of these images may violate intellectual property laws, the laws of privacy and publicity, and communications statutes and regulations. The copyright in this website is owned by the Company. All rights reserved. You are entitled to view, print, and otherwise distribute this document provided that: you use it for informational, non-commercial purposes only; your copy of this document or portion thereof includes this copyright notice; and you do not incorporate your copy (or any part thereof) into other works without the written permission of the Company. ^ top Disclaimer of Liability While the Company uses reasonable efforts to provide accurate and current information on this website, the Company makes no warranties or representations as to its accuracy. The Company assumes no responsibility or liability for any errors or omissions in the content of this website. Without limiting the generality of the foregoing, the documents filed by the Company with securities regulatory authorities and listed on, and/or linked to, this website speak only as of the respective dates on which they are filed by the Company. The contents of those documents can become out-of-date. The Company makes no commitment, and disclaims any duty, to update any of those documents.The Corporation shall not be liable for any damages or injury resulting from your access to, or inability to access, this Site, or from your reliance on any information provided at this Site. Without limiting the foregoing, everything on the Site is provided to you "AS IS" WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESSED OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. ^ top Forward-Looking Statements This website contains forward-looking statements about the Company. Forward-looking statements are statements that are not historical facts, and include financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, research and development, products and services, the impact of regulatory initiatives on the Company's operations, the Company's share of new and existing markets, general industry and macroeconomic growth rates and the Company's performance relative to them, theories regarding the products under development, and other statements regarding future performance. This website may also contain forward-looking statements attributed to third parties relating to their estimates regarding market size and growth. Forward-looking statements can generally be identified by the use of forward-looking terminology or words, such as, "plan", "expected", "exploring new approaches", "anticipates", "believes", "intends", "estimates", "projects", "hopes", "possibility", "designed to", "intended to", "to investigate", "vision", "strategy", "is thought to", "to be used", "envisions" and similar expressions or variations thereon, or statements that events, conditions or results "will", "may", "would", "could", or "should" occur or be achieved. The Company's actual results, performance or achievement could differ significantly from those expressed in, or implied by, the Company's forward-looking statements due to a variety of risks and uncertainties. Forbes is subject to risks associated with being both a publicly traded Company and as an enterprise with several projects in the development-stage operating in the biopharmaceutical industry. The Company cannot predict all of the risk factors, nor can it assess the impact, if any, of such risk factors, on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those projected in any forward-looking statements. Accordingly, forward-looking statements should not be relied upon as a prediction of actual results. Some of the risks and uncertainties affecting the Company, its business, operations and results include, but are not limited to: the Company's need for additional funds, which may not be available on acceptable terms or at all; the Company's dependence on a few customers, the loss of any of which would negatively impact the Company's operations; the need to develop and commercialize new products which will require further time consuming and costly research and development, the success of which cannot be assured; the risk that the Company's theories regarding products under research and development may not be proven, which may result in changing, abandoning or delaying further research or development of such products; the Company's dependency on third parties for cGMP grade raw materials, other materials and for research, development and commercialization assistance and support; the Company's dependency on assurances from third parties regarding licensing of proprietary technology owned by others; government regulation and the need for regulatory approvals for both the development and commercialization of products, which are not assured; uncertainty that the Company's products will be accepted in the marketplace; rapid technological change and competition from pharmaceutical companies, biotechnology companies and universities, which may make the Company's technology or products obsolete or uncompetitive; the need to attract and retain skilled employees; changes in business strategy or development plans; risks associated with claims of infringement of intellectual property and of proprietary rights; risks inherent in manufacturing (including upscaling) and marketing; product liability and insurance risks; risks associated with clinical trials, including the possibility that trials may be terminated early, delayed or unsuccessful; exchange rate fluctuations; political, economic and environmental risks; and the need for performance by buyers and suppliers of products. See the Company's Annual Information Form filed on SEDAR at www.sedar.com for a further description of these and other risks and uncertainties to which the Company is subject. ^ top Links Forbes does not review or control the contents of any linked site. These links do not constitute an endorsement by Forbes of any other websites and Forbes is not responsible for the information contained on such websites. Your linking to any other off-site pages or other sites is at your own risk. ^ top